The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFoxtons Regulatory News (FOXT)

Share Price Information for Foxtons (FOXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.20
Bid: 58.60
Ask: 59.20
Change: 1.20 (2.07%)
Spread: 0.60 (1.024%)
Open: 58.00
High: 59.20
Low: 58.00
Prev. Close: 58.00
FOXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

31 Oct 2019 07:00

RNS Number : 6989R
Foxtons Group PLC
31 October 2019
 

FOXTONS GROUP PLC

Q3 TRADING UPDATE

Thursday 31 October 2019

Foxtons plc (LSE: FOXT), London's leading estate agency, today issues its trading update for the third quarter ended 30 September 2019.

Group revenue for the third quarter was down 7% to £32.5m (Q3 2018: £35.1m). This takes Group revenue for the first nine months of the year to £83.6m, down 5% on the prior year (2018: £88.1m).

Lettings

Improvements to our lettings offer and our decision to not increase fees to landlords following the tenant fee ban has enabled us to grow market share, improve revenue from landlords and increase the penetration of our property management services. Notwithstanding this pleasing progress, as expected the tenant fee ban which came into force on 1 June 2019, resulted in lower revenue for Q3, down 4%, to £22.1m (Q3 2018: £23.1m).

Sales

Ongoing political uncertainty continued to weigh on volumes and prices in the London residential sales market. A combination of lower volumes, falling prices and fewer high value sales meant that sales revenue for the quarter was down 15% to £8.4m (Q3 2018: £9.9m). We believe this to be a resilient performance given the market backdrop.

Mortgage

Revenue in our mortgage business, Alexander Hall, was in line with the same period last year at £2.1m (Q3 2018: £2.1m).

We remain focused on cost control in order to limit the impact of lower revenue on profitability. Cash flow remained healthy in the period, with current cash balances at the same level as this time last year. The Group continues to have no external borrowings.

Nic Budden, CEO, said:

"Overall, this was a resilient performance set against the London sales market which continues to deteriorate and the impact of the tenant fee ban on our lettings business. We are encouraged by landlords' reaction to our improved lettings offer and are confident we can continue to gain share in the London lettings market. We continue to manage costs tightly to ensure the business is well-placed to withstand this prolonged market downturn and are confident that this, coupled with our improved overall offer, positions us well for the future."

Foxtons will issue a pre-close trading update in January 2020 ahead of its full year results at the end of February 2020.

 

For further information, please contact:

Foxtons Group plc

Richard Harris, Chief Financial Officer

Muhammad Patel, Investor Relations

+44 20 7893 6261

investor@foxtonsgroup.co.uk

Teneo

Robert Morgan / Anthony Di Natale

+44 7557 413 275

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFFDILLIVIA
Date   Source Headline
19th Apr 20235:39 pmRNSTransaction in Own Shares
18th Apr 20235:35 pmRNSTransaction in Own Shares
17th Apr 20235:25 pmRNSTransaction in Own Shares
14th Apr 20235:03 pmRNSTransaction in Own Shares
13th Apr 20235:07 pmRNSTransaction in Own Shares
12th Apr 20235:18 pmRNSTransaction in Own Shares
11th Apr 20235:28 pmRNSTransaction in Own Shares
5th Apr 20235:01 pmRNSTransaction in Own Shares
4th Apr 202311:11 amRNSHolding(s) in Company
3rd Apr 20233:44 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:42 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:47 amRNSTotal Voting Rights
31st Mar 202311:01 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAnnual Report and Accounts and Notice of AGM 2023
27th Mar 20235:11 pmRNSTransaction in Own Shares
24th Mar 20235:31 pmRNSTransaction in Own Shares
23rd Mar 20235:02 pmRNSTransaction in Own Shares
22nd Mar 20235:29 pmRNSTransaction in Own Shares
21st Mar 20235:11 pmRNSTransaction in Own Shares
20th Mar 20235:12 pmRNSTransaction in Own Shares
17th Mar 20235:43 pmRNSTransaction in Own Shares
16th Mar 20235:43 pmRNSTransaction in Own Shares
10th Mar 20237:00 amRNSInvestor Presentation
8th Mar 20232:00 pmRNSDirector/PDMR Shareholding
8th Mar 20232:00 pmRNSDirector/PDMR Shareholding
8th Mar 20232:00 pmRNSDirector/PDMR Shareholding
8th Mar 20232:00 pmRNSDirector/PDMR Shareholding
8th Mar 20232:00 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSFinal Results
6th Mar 20237:00 amRNSAcquisition of Atkinson McLeod Limited
24th Feb 202312:57 pmRNSHolding(s) in Company
1st Feb 202311:08 amRNSTotal Voting Rights
27th Jan 20235:29 pmRNSTransaction in Own Shares
27th Jan 202312:27 pmRNSDirectorate Change
26th Jan 20237:00 amRNSUNAUDITED FY22 YEAR END TRADING UPDATE
12th Jan 20235:17 pmRNSTransaction in Own Shares
10th Jan 20235:21 pmRNSTransaction in Own Shares
9th Jan 20235:19 pmRNSTransaction in Own Shares
6th Jan 20235:24 pmRNSTransaction in Own Shares
4th Jan 20235:34 pmRNSTransaction in Own Shares
3rd Jan 20233:45 pmRNSTotal Voting Rights
30th Dec 20221:25 pmRNSTransaction in Own Shares
30th Dec 202211:35 amRNSDirector/PDMR Shareholding
29th Dec 20225:09 pmRNSTransaction in Own Shares
28th Dec 20225:04 pmRNSTransaction in Own Shares
23rd Dec 20227:00 amRNSUpdate on Share Buyback Programme
22nd Dec 20225:06 pmRNSTransaction in Own Shares
21st Dec 20225:38 pmRNSTransaction in Own Shares
20th Dec 20225:36 pmRNSTransaction in Own Shares
19th Dec 20225:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.